Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE

Clinical trial NCT05001737 · COMPLETED

Trial details

NCT number: NCT05001737
Sponsor: Swedish Orphan Biovitrum
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Macrophage Activation Syndrome Secondary Hemophagocytic Lymphohistiocytosis Still Disease Systemic Lupus Erythematosus SJIA AOSD MAS

Start date: 2021-12-15
Primary completion: 2024-06-30
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.